Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Rennebohm

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Arthritis and Rheumatism|November 19, 1997
Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study GroupL G Rider, B M Feldman, M D Perez, et al.
Rheumatology (Oxford, England)|September 25, 2007
The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathyA M Huber, E M Dugan, P A Lachenbruch, et al.
Arthritis and Rheumatism|October 19, 1999
Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study GroupD J Lovell, C B Lindsley, R M Rennebohm, et al.
The Journal of Rheumatology|May 22, 2001
Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study GroupA M Huber, J E Hicks, P A Lachenbruch, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Arthritis and Rheumatism|November 19, 1997
Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study GroupL G Rider, B M Feldman, M D Perez, et al.
Rheumatology (Oxford, England)|September 25, 2007
The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathyA M Huber, E M Dugan, P A Lachenbruch, et al.
Arthritis and Rheumatism|October 19, 1999
Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study GroupD J Lovell, C B Lindsley, R M Rennebohm, et al.
The Journal of Rheumatology|May 22, 2001
Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study GroupA M Huber, J E Hicks, P A Lachenbruch, et al.
Pageof 2